The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
What's in a name? That which we call IPF, by any other name would act the same
Open accessAbstract
Idiopathic pulmonary fibrosis (IPF) remains a truly idiopathic fibrotic disease, with a modest genetic predilection and candidate triggers but no overall explanation for the development of disease in non-familial cases. Agreement on terminology has contributed to major clinical and translational advances since the millennium. It is likely that the entity currently captured by the term “IPF” will be radically reclassified over the next decade, either through “splitting” (into IPF subgroups responding selectively to individual disease-modifying agents) or through “lumping” of IPF with other forms of progressive fibrotic lung disease (with shared pathogenetic mechanisms and IPF-like disease behaviour). In this perspective, we summarise the clinical and pathogenetic justification for a focus on “the progressive fibrotic phenotype” in future clinical and translational research. By this means, we can hope to address the needs of non-IPF patients with inexorably progressive fibrotic disease, currently disenfranchised by lack of access to agents that are efficacious in IPF. In this regard, ongoing trials of anti-fibrotic therapies in non-IPF patients with progressive fibrosis may be highly influential. Future revision of IPF nomenclature may be warranted if there are major conceptual changes but without compelling justification, the benefits of renaming IPF are likely to be outweighed by the resulting confusion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Raghu, G., Collard, H. R., Egan, J. J., Martinez, F. J., Behr, J., Brown, K. K., Colby, T. V., Cordier, J.-F., Flaherty, K. R., Lasky, J. A., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2009-040gl · Cited by 7,186
Self-citationEfficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Richeldi, L., du Bois, R. M., Raghu, G., Azuma, A., Brown, K. K., Costabel, U., Cottin, V., Flaherty, K. R., Hansell, D. M., Inoue, Y., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402584 · Cited by 4,654
Self-citationTravis, W. D., Costabel, U., Hansell, D. M., King, T. E., Lynch, D. A., Nicholson, A. G., Ryerson, C. J., Ryu, J. H., Selman, M., Wells, A. U., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201308-1483st · Cited by 4,290
Self-citation(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.2.ats01 · Cited by 4,196
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
King, T. E., Bradford, W. Z., Castro-Bernardini, S., Fagan, E. A., Glaspole, I., Glassberg, M. K., Gorina, E., Hopkins, P. M., Kardatzke, D., Lancaster, L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402582 · Cited by 3,975
Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment: International Consensus Statement
(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.ats3-00 · Cited by 2,628
A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation
Ramsey, B. W., Davies, J., McElvaney, N. G., Tullis, E., Bell, S. C., Dřevínek, P., Griese, M., McKone, E. F., Wainwright, C. E., Konstan, M. W., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105185 · Cited by 2,195
Raghu, G., Rochwerg, B., Zhang, Y., Garcia, C. A. C., Azuma, A., Behr, J., Brozek, J. L., Collard, H. R., Cunningham, W., Homma, S., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201506-1063st · Cited by 1,916
Self-citationSelman, M., King, T. E., & Pardo, A. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-2-200101160-00015 · Cited by 1,786
Cyclophosphamide versus placebo in scleroderma lung disease
Tashkin, D. P., Elashoff, R., Clements, P. J., Goldin, J., Roth, M. D., Furst, D. E., Arriola, E., Silver, R., Strange, C., Bolster, M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055120 · Cited by 1,677
Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma
Bel, E. H., Wenzel, S. E., Thompson, P. J., Prazma, C. M., Keene, O. N., Yancey, S. W., Ortega, H. G., & Pavord, I. D. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1403291 · Cited by 1,661
Lebrikizumab Treatment in Adults with Asthma
Corren, J., Lemanske, R. F., Hanania, N. A., Korenblat, P. E., Parsey, M. V., Arron, J. R., Harris, J. M., Scheerens, H., Wu, L. C., Su, Z., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1106469 · Cited by 1,514
Telomerase Mutations in Families with Idiopathic Pulmonary Fibrosis
Armanios, M. Y., Chen, J. J.-L., Cogan, J. D., Alder, J. K., Ingersoll, R. G., Markin, C., Lawson, W. E., Xie, M., Vulto, I., Phillips, J. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066157 · Cited by 1,357
A Common MUC5B Promoter Polymorphism and Pulmonary Fibrosis
Seibold, M. A., Wise, A. L., Speer, M. C., Steele, M. P., Brown, K. K., Loyd, J. E., Fingerlin, T. E., Zhang, W., Gudmundsson, G., Groshong, S. D., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1013660 · Cited by 1,198
Self-citationFischer, A., Antoniou, K. M., Brown, K. K., Cadranel, J., Corte, T. J., du Bois, R. M., Lee, J. S., Leslie, K. O., Lynch, D. A., Matteson, E. L., et al. (2015) · European Respiratory Journal · doi:10.1183/13993003.00150-2015 · Cited by 1,099
Self-citationTashkin, D. P., Roth, M. D., Clements, P. J., Furst, D. E., Khanna, D., Kleerup, E. C., Goldin, J., Arriola, E., Volkmann, E. R., Kafaja, S., et al. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(16)30152-7 · Cited by 1,078
Bronchiolitis Obliterans Organizing Pneumonia
Epler, G. R., Colby, T. V., McLoud, T. C., Carrington, C. B., & Gaensler, E. A. (1985) · New England Journal of Medicine · doi:10.1056/nejm198501173120304 · Cited by 1,046
Oral Glucocorticoid–Sparing Effect of Benralizumab in Severe Asthma
Nair, P., Wenzel, S., Rabe, K. F., Bourdin, A., Lugogo, N. L., Kuna, P., Barker, P., Sproule, S., Ponnarambil, S., & Goldman, M. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1703501 · Cited by 1,044
Prognostic Significance of Histopathologic Subsets in Idiopathic Pulmonary Fibrosis
BJORAKER, J. A., RYU, J. H., EDWIN, M. K., MYERS, J. L., TAZELAAR, H. D., SCHROEDER, D. R., & OFFORD, K. P. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.1.9704130 · Cited by 1,039
Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper
Lynch, D. A., Sverzellati, N., Travis, W. D., Brown, K. K., Colby, T. V., Galvin, J. R., Goldin, J. G., Hansell, D. M., Inoue, Y., Johkoh, T., et al. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30433-2 · Cited by 1,030
Self-citationCombined pulmonary fibrosis and emphysema: a distinct underrecognised entity
Cottin, V., Nunes, H., Brillet, P.-Y., Delaval, P., Devouassoux, G., Tillie-Leblond, I., Israel-Biet, D., Court-Fortune, I., Valeyre, D., & Cordier, J.-F. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00021005 · Cited by 1,004
Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis
Fingerlin, T. E., Murphy, E., Zhang, W., Peljto, A. L., Brown, K. K., Steele, M. P., Loyd, J. E., Cosgrove, G. P., Lynch, D., Groshong, S., et al. (2013) · Nature Genetics · doi:10.1038/ng.2609 · Cited by 809
Self-citationNatural History and Treated Course of Usual and Desquamative Interstitial Pneumonia
Carrington, C. B., Gaensler, E. A., Coutu, R. E., FitzGerald, M. X., & Gupta, R. G. (1978) · New England Journal of Medicine · doi:10.1056/nejm197804132981501 · Cited by 791
Nonspecific Interstitial Pneumonia/Fibrosis: Histologic Features and Clinical Significance
Katzenstein, A.-L. A., & Fiorelli, R. F. (1994) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199402000-00003 · Cited by 755
Crystal, R. G., Bitterman, P. B., Rennard, S. I., Hance, A. J., & Keogh, B. A. (1984) · New England Journal of Medicine · doi:10.1056/nejm198401193100304 · Cited by 690
Reversal of persistent fibrosis in aging by targeting Nox4-Nrf2 redox imbalance
Hecker, L., Logsdon, N. J., Kurundkar, D., Kurundkar, A., Bernard, K., Hock, T., Meldrum, E., Sanders, Y. Y., & Thannickal, V. J. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008182 · Cited by 686
Self-citationNoth, I., Zhang, Y., Ma, S.-F., Flores, C., Barber, M., Huang, Y., Broderick, S. M., Wade, M. S., Hysi, P., Scuirba, J., et al. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70045-6 · Cited by 614
Sleijfer, S. (2001) · Chest · doi:10.1378/chest.120.2.617 · Cited by 611
Park, J. H., Kim, D. S., Park, I.-N., Jang, S. J., Kitaichi, M., Nicholson, A. G., & Colby, T. V. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200607-912oc · Cited by 597
MMP1 and MMP7 as Potential Peripheral Blood Biomarkers in Idiopathic Pulmonary Fibrosis
Rosas, I. O., Richards, T. J., Konishi, K., Zhang, Y., Gibson, K., Lokshin, A. E., Lindell, K. O., Cisneros, J., MacDonald, S. D., Pardo, A., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050093 · Cited by 588
Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease
Kim, E. J., Elicker, B. M., Maldonado, F., Webb, W. R., Ryu, J. H., Van Uden, J. H., Lee, J. S., King, T. E., & Collard, H. R. (2010) · European Respiratory Journal · doi:10.1183/09031936.00092309 · Cited by 587
Fibrotic Idiopathic Interstitial Pneumonia: The Prognostic Value of Longitudinal Functional Trends
Latsi, P. I., du Bois, R. M., Nicholson, A. G., Colby, T. V., Bisirtzoglou, D., Nikolakopoulou, A., Veeraraghavan, S., Hansell, D. M., & Wells, A. U. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200210-1245oc · Cited by 583
Self-citationKelly, C. A., Saravanan, V., Nisar, M., Arthanari, S., Woodhead, F. A., Price-Forbes, A. N., Dawson, J., Sathi, N., Ahmad, Y., Koduri, G., et al. (2014) · Rheumatology · doi:10.1093/rheumatology/keu165 · Cited by 549
Fibrotic extracellular matrix activates a profibrotic positive feedback loop
Parker, M. W., Rossi, D., Peterson, M., Smith, K., Sikström, K., White, E. S., Connett, J. E., Henke, C. A., Larsson, O., & Bitterman, P. B. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71386 · Cited by 548
Hanania, N. A., Korenblat, P., Chapman, K. R., Bateman, E. D., Kopecky, P., Paggiaro, P., Yokoyama, A., Olsson, J., Gray, S., Holweg, C. T. J., et al. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(16)30265-x · Cited by 469
Zhou, Y., Huang, X., Hecker, L., Kurundkar, D., Kurundkar, A., Liu, H., Jin, T.-H., Desai, L., Bernard, K., & Thannickal, V. J. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66700 · Cited by 455
Self-citationPeljto, A. L., Zhang, Y., Fingerlin, T. E., Ma, S.-F., Garcia, J. G. N., Richards, T. J., Silveira, L. J., Lindell, K. O., Steele, M. P., Loyd, J. E., et al. (2013) · JAMA · doi:10.1001/jama.2013.5827 · Cited by 453
Self-citationFischer, A., Brown, K. K., Du Bois, R. M., Frankel, S. K., Cosgrove, G. P., Fernandez-Perez, E. R., Huie, T. J., Krishnamoorthy, M., Meehan, R. T., Olson, A. L., et al. (2013) · The Journal of Rheumatology · doi:10.3899/jrheum.121043 · Cited by 397
Self-citationPredictors of mortality in rheumatoid arthritis-associated interstitial lung disease
Solomon, J. J., Chung, J. H., Cosgrove, G. P., Demoruelle, M. K., Fernandez-Perez, E. R., Fischer, A., Frankel, S. K., Hobbs, S. B., Huie, T. J., Ketzer, J., et al. (2016) · European Respiratory Journal · doi:10.1183/13993003.00357-2015 · Cited by 388
Self-citationPeripheral blood proteins predict mortality in idiopathic pulmonary fibrosis
Richards, T. J., Kaminski, N., Baribaud, F., Flavin, S., Brodmerkel, C., Horowitz, D., Li, K., Choi, J., Vuga, L. J., Lindell, K. O., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201101-0058oc · Cited by 381
Goh, N. S., Hoyles, R. K., Denton, C. P., Hansell, D. M., Renzoni, E. A., Maher, T. M., Nicholson, A. G., & Wells, A. U. (2017) · Arthritis & Rheumatology · doi:10.1002/art.40130 · Cited by 354
Self-citationOldham, J. M., Ma, S.-F., Martinez, F. J., Anstrom, K. J., Raghu, G., Schwartz, D. A., Valenzi, E., Witt, L., Lee, C., Vij, R., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201505-1010oc · Cited by 341
Prescott, H. C., Calfee, C. S., Thompson, B. T., Angus, D. C., & Liu, V. X. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201512-2544cp · Cited by 322
Prevalence and prognosis of unclassifiable interstitial lung disease
Ryerson, C. J., Urbania, T. H., Richeldi, L., Mooney, J. J., Lee, J. S., Jones, K. D., Elicker, B. M., Koth, L. L., King, T. E., Wolters, P. J., et al. (2013) · European Respiratory Journal · doi:10.1183/09031936.00131912 · Cited by 310
Physiology Is a Stronger Predictor of Survival than Pathology in Fibrotic Interstitial Pneumonia
Jegal, Y., Kim, D. S., Shim, T. S., Lim, C.-M., Do Lee, S., Koh, Y., Kim, W. S., Kim, W. D., Lee, J. S., Travis, W. D., et al. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200403-331oc · Cited by 308
Ley, B., Newton, C. A., Arnould, I., Elicker, B. M., Henry, T. S., Vittinghoff, E., Golden, J. A., Jones, K. D., Batra, K., Torrealba, J., et al. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30216-3 · Cited by 296
DePianto, D. J., Chandriani, S., Abbas, A. R., Jia, G., N'Diaye, E. N., Caplazi, P., Kauder, S. E., Biswas, S., Karnik, S. K., Ha, C., et al. (2015) · Thorax · doi:10.1136/thoraxjnl-2013-204596 · Cited by 287
Cao, Z., Lis, R., Ginsberg, M., Chavez, D., Shido, K., Rabbany, S. Y., Fong, G.-H., Sakmar, T. P., Rafii, S., & Ding, B.-S. (2016) · Nature Medicine · doi:10.1038/nm.4035 · Cited by 285
Characterisation of patients with interstitial pneumonia with autoimmune features
Oldham, J. M., Adegunsoye, A., Valenzi, E., Lee, C., Witt, L., Chen, L., Husain, A. N., Montner, S., Chung, J. H., Cottin, V., et al. (2016) · European Respiratory Journal · doi:10.1183/13993003.01565-2015 · Cited by 275
Stage IV sarcoidosis: comparison of survival with the general population and causes of death
Nardi, A., Brillet, P.-Y., Letoumelin, P., Girard, F., Brauner, M., Uzunhan, Y., Naccache, J.-M., Valeyre, D., & Nunes, H. (2011) · European Respiratory Journal · doi:10.1183/09031936.00187410 · Cited by 272
Beasley, M. B., Franks, T. J., Galvin, J. R., Gochuico, B., & Travis, W. D. (2002) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2002-126-1064-afaop · Cited by 255
Morisset, J., Johannson, K. A., Vittinghoff, E., Aravena, C., Elicker, B. M., Jones, K. D., Fell, C. D., Manganas, H., Dubé, B.-P., Wolters, P. J., et al. (2017) · CHEST · doi:10.1016/j.chest.2016.10.029 · Cited by 243
Fibrosis: ultimate and proximate causes
Thannickal, V. J., Zhou, Y., Gaggar, A., & Duncan, S. R. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74368 · Cited by 242
Self-citationJuge, P.-A., Borie, R., Kannengiesser, C., Gazal, S., Revy, P., Wemeau-Stervinou, L., Debray, M.-P., Ottaviani, S., Marchand-Adam, S., Nathan, N., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.02314-2016 · Cited by 232
Stock, C. J., Sato, H., Fonseca, C., Banya, W. A. S., Molyneaux, P. L., Adamali, H., Russell, A.-M., Denton, C. P., Abraham, D. J., Hansell, D. M., et al. (2013) · Thorax · doi:10.1136/thoraxjnl-2012-201786 · Cited by 231
Self-citationLung diseases directly associated with rheumatoid arthritis and their relationship to outcome
Tsuchiya, Y., Takayanagi, N., Sugiura, H., Miyahara, Y., Tokunaga, D., Kawabata, Y., & Sugita, Y. (2011) · European Respiratory Journal · doi:10.1183/09031936.00019210 · Cited by 223
Pérez-Padilla, R., Salas, J., Chapela, R., Sánchez, M., Carrillo, G., Pérez, R., Sansores, R., Gaxiola, M., & Selman, M. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/148.1.49 · Cited by 222
Walsh, S. L. F., Sverzellati, N., Devaraj, A., Wells, A. U., & Hansell, D. M. (2012) · European Radiology · doi:10.1007/s00330-012-2427-0 · Cited by 197
Self-citationTime for a change: is idiopathic pulmonary fibrosis still idiopathic and only fibrotic?
Wolters, P. J., Blackwell, T. S., Eickelberg, O., Loyd, J. E., Kaminski, N., Jenkins, G., Maher, T. M., Molina-Molina, M., Noble, P. W., Raghu, G., et al. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30007-9 · Cited by 196
Kahloon, R. A., Xue, J., Bhargava, A., Csizmadia, E., Otterbein, L., Kass, D. J., Bon, J., Soejima, M., Levesque, M. C., Lindell, K. O., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201203-0506oc · Cited by 190
Change in FVC and survival in chronic fibrotic hypersensitivity pneumonitis
Gimenez, A., Storrer, K., Kuranishi, L., Soares, M. R., Ferreira, R. G., & Pereira, C. A. C. (2018) · Thorax · doi:10.1136/thoraxjnl-2017-210035 · Cited by 184
Flaherty, K. R., Brown, K. K., Wells, A. U., Clerisme-Beaty, E., Collard, H. R., Cottin, V., Devaraj, A., Inoue, Y., Le Maulf, F., Richeldi, L., et al. (2017) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2017-000212 · Cited by 184
Self-citationWhite, E. S., Xia, M., Murray, S., Dyal, R., Flaherty, C. M., Flaherty, K. R., Moore, B. B., Cheng, L., Doyle, T. J., Villalba, J., et al. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201505-0862oc · Cited by 180
Self-citationEffect of nintedanib in subgroups of idiopathic pulmonary fibrosis by diagnostic criteria
Raghu, G., Wells, A. U., Nicholson, A. G., Richeldi, L., Flaherty, K. R., Le Maulf, F., Stowasser, S., Schlenker-Herceg, R., & Hansell, D. M. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201602-0402oc · Cited by 180
Self-citationPathologic Patterns and Survival in Chronic Hypersensitivity Pneumonitis
Churg, A., Sin, D. D., Everett, D., Brown, K., & Cool, C. (2009) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181bb2538 · Cited by 173
Self-citationMitochondria, telomeres and cell senescence: Implications for lung ageing and disease
Birch, J., Barnes, P. J., & Passos, J. F. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.10.005 · Cited by 170
Fulminating Diffuse Interstitial Fibrosis of the Lungs.
Hamman, L., & Rich, A. R. (1935) · PubMed · Cited by 169
Wang, P., Jones, K. D., Urisman, A., Elicker, B. M., Urbania, T., Johannson, K. A., Assayag, D., Lee, J., Wolters, P. J., Collard, H. R., et al. (2017) · Chest · doi:10.1016/j.chest.2017.02.011 · Cited by 165
Cellular and Humoral Autoreactivity in Idiopathic Pulmonary Fibrosis
Feghali-Bostwick, C. A., Tsai, C. G., Valentine, V. G., Kantrow, S., Stoner, M. W., Pilewski, J. M., Gadgil, A., George, M. P., Gibson, K. F., Choi, A. M. K., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.4.2592 · Cited by 160
Aberrant expression and activity of histone deacetylases in sporadic idiopathic pulmonary fibrosis
Korfei, M., Skwarna, S., Henneke, I., MacKenzie, B., Klymenko, O., Saito, S., Ruppert, C., von der Beck, D., Mahavadi, P., Klepetko, W., et al. (2015) · Thorax · doi:10.1136/thoraxjnl-2014-206411 · Cited by 144
Assayag, D., Elicker, B. M., Urbania, T. H., et al. (2013) · Radiology · doi:10.1148/radiol.13130187 · Cited by 135
Outcomes of immunosuppressive therapy in chronic hypersensitivity pneumonitis
Adegunsoye, A., Oldham, J. M., Pérez, E. R. F., Hamblin, M., Patel, N. M., Tener, M., Bhanot, D., Robinson, L. B., Bullick, S., Chen, L. W., et al. (2017) · ERJ Open Research · doi:10.1183/23120541.00016-2017 · Cited by 132
Short telomere length in IPF lung associates with fibrotic lesions and predicts survival
Snetselaar, R., van Batenburg, A. A., van Oosterhout, M. F. M., Kazemier, K. M., Roothaan, S. M., Peeters, T., van der Vis, J. J., Goldschmeding, R., Grutters, J. C., & van Moorsel, C. H. M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0189467 · Cited by 126
Autoantibody-targeted treatments for acute exacerbations of idiopathic pulmonary fibrosis
Donahoe, M., Valentine, V. G., Chien, N., Gibson, K. F., Raval, J. S., Saul, M., Xue, J., Zhang, Y., & Duncan, S. R. (2015) · PLOS ONE · doi:10.1371/journal.pone.0127771 · Cited by 125
Age-driven developmental drift in the pathogenesis of idiopathic pulmonary fibrosis
Selman, M., López-Otín, C., & Pardo, A. (2016) · European Respiratory Journal · doi:10.1183/13993003.00398-2016 · Cited by 122
Behr, J., Neuser, P., Prasse, A., Kreuter, M., Rabe, K. F., Schade‐Brittinger, C., Wagner, J., & Günther, A. (2017) · BMC Pulmonary Medicine · doi:10.1186/s12890-017-0462-y · Cited by 121
Mechanistic links between aging and lung fibrosis
Thannickal, V. J. (2013) · Biogerontology · doi:10.1007/s10522-013-9451-6 · Cited by 118
Self-citationGiant-Cell Interstitial Pneumonia and Hard-Metal Pneumoconiosis
Ohori, N. P., Sciurba, F. C., Owens, G. R., Hodgson, M. J., & Yousem, S. A. (1989) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198907000-00006 · Cited by 117
Yunt, Z. X., Chung, J. H., Hobbs, S., et al. (2017) · Respiratory Medicine · doi:10.1016/j.rmed.2017.03.027 · Cited by 116
Moua, T., Martínez, A. C., Baqir, M., Vassallo, R., LIMPER, A. H., & Ryu, J. H. (2014) · Respiratory Research · doi:10.1186/s12931-014-0154-6 · Cited by 95
Epithelial stem cell exhaustion in the pathogenesis of idiopathic pulmonary fibrosis.
Chilosi, M., Doglioni, C., Murer, B., & Poletti, V. E. (2010) · Sarcoidosis vasculitis and diffuse lung diseases · Cited by 90
Rheumatoid lung disease: Prognostic analysis of 54 biopsy-proven cases
Nakamura, Y., Suda, T., Kaida, Y., et al. (2012) · Respiratory Medicine · doi:10.1016/j.rmed.2012.04.004 · Cited by 89
Management of suspected monogenic lung fibrosis in a specialised centre
Borie, R., Kannengiesser, C., de Fontbrune, F. S., Gouya, L., Nathan, N., & Crestani, B. (2017) · European Respiratory Review · doi:10.1183/16000617.0122-2016 · Cited by 85
Genetics of idiopathic pulmonary fibrosis: from mechanistic pathways to personalised medicine
Spagnolo, P., & Cottin, V. (2016) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2016-103973 · Cited by 82
Alveolar epithelial disintegrity in pulmonary fibrosis
Kulkarni, T., de Andrade, J. A., Zhou, Y., Luckhardt, T., & Thannickal, V. J. (2016) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00115.2016 · Cited by 80
Self-citationPulmonary fibrosis in the era of stratified medicine
Mathai, S. K., Newton, C. A., Schwartz, D. A., & Garcia, C. K. (2016) · Thorax · doi:10.1136/thoraxjnl-2016-209172 · Cited by 77
Nurmi, H., Kettunen, H.-P., Suoranta, S.-K., Purokivi, M., Kärkkäinen, M. S., Selander, T. A., & Kaarteenaho, R. L. (2017) · Respiratory Medicine · doi:10.1016/j.rmed.2017.11.013 · Cited by 66
Surolia, R., Li, F. J., Wang, Z., Li, H., Liu, G., Zhou, Y., Luckhardt, T., Bae, S., Liu, R.-M., Rangarajan, S., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.91377 · Cited by 65
Self-citationOrganizing Pneumonia-like Process
Grinblat, J., Mechlis, S., & LEWITUS, Z. (1981) · CHEST Journal · doi:10.1378/chest.80.3.259 · Cited by 62
Interstitial lung diseases: characteristics at diagnosis and mortality risk assessment
Thomeer, M., Vansteenkiste, J., Verbeken, E. K., & Demedts, M. (2004) · Respiratory Medicine · doi:10.1016/j.rmed.2003.10.015 · Cited by 57
Unclassifiable-interstitial lung disease: Outcome prediction using CT and functional indices
Jacob, J., Bartholmai, B. J., Rajagopalan, S., Egashira, R., Brun, A., Kokosi, M. A., Nair, A., Walsh, S. L. F., Karwoski, R. A., Nicholson, A. G., et al. (2017) · Respiratory Medicine · doi:10.1016/j.rmed.2017.07.007 · Cited by 57
Self-citationChanda, D., Kurundkar, A., Rangarajan, S., Locy, M. L., Bernard, K. F., Sharma, N., Logsdon, N. J., Liu, H., Crossman, D. K., Horowitz, J. C., et al. (2016) · Scientific Reports · doi:10.1038/srep37445 · Cited by 56
Self-citationKennedy, B., Branagan, P., Moloney, F., Haroon, M., O’Connell, O. J., O’Connor, T. M., O'Regan, K. N., Harney, S., & Henry, M. T. (2015) · Sarcoidosis vasculitis and diffuse lung diseases · Cited by 53
Abraham, J. L., Burnett, B. R., & Hunt, A. (1991) · PubMed · Cited by 51
Personalized medicine in idiopathic pulmonary fibrosis: facts and promises
Spagnolo, P., Τzouvelekis, Α., & Maher, T. M. (2015) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000187 · Cited by 48
Systemic sclerosis-associated fibrosis: an accelerated aging phenotype?
Luckhardt, T., & Thannickal, V. J. (2015) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000219 · Cited by 39
Self-citationPennathur, S., Vivekanandan-Giri, A., Locy, M. L., Kulkarni, T., Zhi, D., Zeng, L., Byun, J., de Andrade, J. A., & Thannickal, V. J. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201505-0992oc · Cited by 36
Self-citationIdiopathic pulmonary fibrosis: idiopathic no more?
Thannickal, V. J., Wells, A. U., & Kolb, M. R. J. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30022-5 · Cited by 10
Self-citationApproach to Diagnosis of Diffuse Lung Disease
Wells, A. U. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4557-0792-8.00046-5 · Cited by 4
Self-citationPersonalised medicine for IPF: getting closer, but not there yet
Sato, S., & Kolb, M. R. J. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30348-x · Cited by 3
Self-citation
Cited by
Raghu, G., Remy-Jardin, M., Richeldi, L., Thomson, C. C., Inoue, Y., Johkoh, T., Kreuter, M., Lynch, D. A., Maher, T. M., Martinez, F. J., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202202-0399st · Cited by 2,957
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
Flaherty, K. R., Wells, A. U., Cottin, V., Devaraj, A., Walsh, S. L. F., Inoue, Y., Richeldi, L., Kolb, M., Tetzlaff, K., Stowasser, S., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1908681 · Cited by 2,403
Self-citationSpectrum of fibrotic lung diseases
Wijsenbeek, M., & Cottin, V. (2020) · New England Journal of Medicine · doi:10.1056/nejmra2005230 · Cited by 736
Cottin, V., Hirani, N. A., Hotchkin, D. L., Nambiar, A. M., Ogura, T., Otaola, M., Skowasch, D., Park, J. S., Poonyagariyagorn, H. K., Wuyts, W., et al. (2018) · European Respiratory Review · doi:10.1183/16000617.0076-2018 · Cited by 652
Self-citationWells, A. U., Flaherty, K. R., Brown, K. K., Inoue, Y., Devaraj, A., Richeldi, L., Moua, T., Crestani, B., Wuyts, W. A., Stowasser, S., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30036-9 · Cited by 569
Self-citation
Metadata
- Authors
- Wells, A. U., Brown, K. K., Flaherty, K. R., Kolb, M., & Thannickal, V. J.
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2018-05
- Volume
- 51
- Issue
- 5
- Pages
- 1800692
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W2804065941
- Cited by
- 352
- References
- 100
- FWCI
- 29.25
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.